
|Videos|November 16, 2021
Dr. Bander gives an overview of PSMA-PET imaging innovations
Author(s)Urology Times staff
“It's very clear that PSMA-PET imaging is having…a transformative impact on our ability to image metastatic disease, in that it is much more sensitive than we've had for the last 50 plus years—and also, 98% specific,” says Neil H. Bander, MD.
Advertisement
In this video, Neil H. Bander, MD, discusses innovations in PSMA-PET imaging for patients with prostate cancer and how these breakthroughs will change diagnosis and treatment. Bander is the Bernard & Josephine Chaus professor of Urologic Oncology at Weill Cornell Medicine, New York City, New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Published VAPOR 2 data evaluate water vapor ablation for localized prostate cancer
2
From OR to office: How Break Wave changes urology practice workflow
3
Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer
4
HoLEP patient selection and the technical error most surgeons make past training
5












